Results 141 to 150 of about 320,592 (205)

Decoding the glycan shield: Immune recognition and response to the HIV-1 envelope trimer. [PDF]

J Biol Chem
Nawaz FZ, Adams TM, Demirturk ME, Avci FY.   +3 more
europepmc   +1 more source

Antigen heterogeneity in the development and clinical validation of a multiplexed urine test for tuberculosis. [PDF]

Commun Med (Lond)
Dougan TJ, Roth S, Xie L, D'Amaddio S, Walt DR.   +4 more
europepmc   +1 more source

Breast milk antibody Fc signatures track with HIV transmission during breastfeeding in ART-naïve mothers. [PDF]

iScience
Nziza N, Jung W, Lee Y, Hsiao JC, Chen T, Li F, Atyeo C, Lauffenburger DA, Kuhn L, Tobin NH, Aldrovandi GM, Alter G, Julg B.   +12 more
europepmc   +1 more source

Harnessing conserved epitopes and multivalent antigen strategies for vaccine design: Lessons learned and opportunities. [PDF]

Hum Vaccin Immunother
Adjei-Gati E, Quaye CNO, Lamptey PO, Oklu LD, Kwofie JN, Hafiz YA, Kusi KA.   +6 more
europepmc   +1 more source

Versatile HIV Rev-dependent reporter cell system for stringent and sensitive quantification of viral reservoirs, neutralizing antibodies, and restriction factors. [PDF]

Retrovirology
Spear M, Choi J, Hetrick B, Lee J, Lê-Bury G, Vo TT, Han Y, Liang H, Guo J, Yu D, Iyer S, Mwandumba HC, Russell DG, Wu Y, Gludish DW.   +14 more
europepmc   +1 more source

The Medical Abnormality of Homosexuality [PDF]

, 2003
Flanagan, Michael Brendan
core   +1 more source

Mumps disease and vaccination in Africa: A scoping review. [PDF]

Hum Vaccin Immunother
Gobe I, Mogowa T, Kadimo K, Tlhakanelo JT, Motswaledi M.   +4 more
europepmc   +1 more source

Framework-mediated binding of foreign and self-glycans by IGHV4-34 antibodies. [PDF]

Front Immunol
Langley DB, Jara CJ, Henry JY, Reed JH, Goodnow CC, Christ D.   +5 more
europepmc   +1 more source

Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection. [PDF]

Front Immunol
Grunst MW, Li W, Mothes W.
europepmc   +1 more source

Modulation of IRF7-driven transcription as a strategy to control HIV-1 latency. [PDF]

Front Immunol
Ezeonwumelu IJ, Garcia-Vidal E, Felip E, Cabrero-de Las Heras S, Clotet B, Badia R, Ballana E, Riveira-Muñoz E, Nevot M.   +8 more
europepmc   +1 more source